Diabetologia

Papers
(The H4-Index of Diabetologia is 47. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Not all very-low-carbohydrate diets are created equal. Reply to Conte C, Camajani E, Lai A, Caprio M [letter]513
Brown adipose tissue alleviates podocyte apoptosis through NRG4 in a male mouse model of diabetic kidney disease219
Genome-wide association study identifying novel risk variants associated with glycaemic traits in the continental African AWI-Gen cohort202
Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention. Reply to Pouwer F, Deschênes SS [letter]199
Cardiac arrhythmia and hypoglycaemia among individuals with and without diabetes receiving haemodialysis (the CADDY study): a Danish multicentre cohort study180
Plasma metabolite profiles related to plant-based diets and the risk of type 2 diabetes159
Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial130
Branding foods as ‘healthy’ or ‘unhealthy’ based on marginal data calls findings into question. Reply to Kanter M [letter]128
High glucose/ChREBP-induced Hif-1α transcriptional activation in CD4+ T cells reduces the risk of diabetic kidney disease by inhibiting the Th1 response115
The insulin hypersecretion hypothesis: cause or effect? Reply to Polychronakos C [letter]104
Dyslipidaemia as a target for atherosclerotic cardiovascular disease prevention in children with type 1 diabetes: lessons learned from familial hypercholesterolaemia103
Potential confounders in the association between per- and polyfluoroalkyl substance exposure and diabetes103
58th EASD Annual Meeting of the European Association for the Study of Diabetes102
Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: a randomised trial to assess effects on endothelial function, platelet activation and vascu96
Up Front95
Up Front87
Determination of autoantibodies in type 2 diabetes: one simple way to improve classification87
Scientists and scientific journals should adhere to ethical standards for the use and reporting of data from Indigenous people74
Higher maternal adiposity reduces offspring birthweight if associated with a metabolically favourable profile73
Presymptomatic type 1 diabetes and disease severity at onset. Reply to Schneider J, Gemulla G, Kiess W et al [letter]73
Transcriptomic heterogeneity of non-beta islet cells is associated with type 2 diabetes development in mouse models70
Characterisation of enterovirus RNA detected in the pancreas and other specimens of live patients with newly diagnosed type 1 diabetes in the DiViD study69
Risk for ketonaemia in type 1 diabetes pregnancies with sensor-augmented pump therapy with predictive low glucose suspend compared with low glucose suspend: a crossover RCT68
Gut microbiota mediate melatonin signalling in association with type 2 diabetes68
Up Front66
Kidney outcomes and all-cause mortality in people with type 2 diabetes exhibiting non-albuminuric kidney insufficiency65
Advanced glycation end-products, cardiac function and heart failure in the general population: The Rotterdam Study65
Effectiveness and safety of empagliflozin: final results from the EMPRISE study64
The efficacy of islet autoantibody screening with or without genetic pre-screening strategies for the identification of presymptomatic type 1 diabetes63
The gut microbiota and diabetes: clarity on an emerging topic and introduction to a new partnership and journal feature62
57 th EASD Annual Meeting of the European Association for the Study of Diabetes61
Up Front57
Environmental exposures are important for type 2 diabetes pathophysiology in sub-Saharan African populations57
Up Front56
Young age at diabetes diagnosis amplifies the effect of diabetes duration on risk of chronic kidney disease: a prospective cohort study56
Stratifying risk for onset of type 1 diabetes using islet autoantibody trajectory clustering55
HAND2 is a novel obesity-linked adipogenic transcription factor regulated by glucocorticoid signalling55
Diabetes knowledge and behaviour: a cross-sectional study of Jordanian adults54
Identification and interpretation of risk factors for Charcot foot. Reply to Milbourn VEL, Bus SA, Game F, van Netten JJ [letter]54
Patient-reported outcomes for people with diabetes: what and how to measure? A narrative review53
Integrated glycomics and genetics analyses reveal a potential role for N-glycosylation of plasma proteins and IgGs, as well as the complement system, in the development of type 1 diabetes51
Causal factors underlying diabetes risk informed by Mendelian randomisation analysis: evidence, opportunities and challenges51
Infant gut microbiome composition correlated with type 1 diabetes acquisition in the general population: the ABIS study50
Plasma proteomic signatures of a direct measure of insulin sensitivity in two population cohorts49
Not all very-low-carbohydrate diets are created equal49
Glycaemic control, risk of hypoglycaemia and all-cause mortality in new users of second-generation basal insulin with type 2 diabetes and chronic kidney disease: a nationwide register-based cohort stu49
Incretins beyond type 2 diabetes48
Using race as a social construct when looking at differences in racial associations between non-alcoholic fatty liver disease and type 2 diabetes47
Comments on the notion of false positivity in measurements of autoantibodies47
Atorvastatin lowers 68Ga-DOTATATE uptake in coronary arteries, bone marrow and spleen in individuals with type 2 diabetes47
0.07451319694519